Alentis Therapeutics
alentis.chLocations
Basel, Switzerland · Basel City, Switzerland · Basel-Landschaft, Switzerland
industry
Pharmaceuticals
Size
51 - 200 employees
Stage
Other
founded in
2019
Alentis Therapeutics, the CLDN1 company, is a clinical-stage biotech investigating novel therapeutics for CLDN1+ cancers. Alentis is the pioneering business in the use of anti-CLDN1 ADCs and antibodies to modify and reverse the progression of certain diseases.
Something looks off?Open jobs at Alentis Therapeutics
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.